U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula Cr
Molecular Weight 51.9961
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHROMIUM

SMILES

[Cr]

InChI

InChIKey=VYZAMTAEIAYCRO-UHFFFAOYSA-N
InChI=1S/Cr

HIDE SMILES / InChI
Nearly 60 years ago, chromium, as the trivalent ion, was proposed to be an essential element, but the results of new studies indicate that chromium currently can only be considered pharmacologically active and not an essential element. Chromium is a mineral that humans need in very small quantities. Good sources include broccoli, liver, and brewers' yeast. Taking chromium by mouth is effective for preventing chromium deficiency. It is also taken by mouth for depression, Turner's syndrome, polycystic ovary syndrome (PCOS), lowering "bad" cholesterol, raising "good" cholesterol in people taking heart medications called beta blockers, obesity, metabolic syndrome, heart attack, schizophrenia, bipolar disorder, binge eating disorder, and a disease called reactive hypoglycemia. Chromium has been marketed as an agent to reduce body mass and develop muscle; however, such marketing claims are no longer allowed in the United States because they are not supported by experiments. Trivalent chromium has also been proposed as a therapeutic agent to increase insulin sensitivity and affect lipid metabolism. Although effective in certain rodent models, beneficial effects in humans have not been unequivocally established.

Approval Year

PubMed

PubMed

TitleDatePubMed
Enhancement of jejunal absorption of conjugated bile acid by neurotensin in rats.
2001 Jan
Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats.
2003 Jul-Sep
Chromium inhibits transcription from polycyclic aromatic hydrocarbon-inducible promoters by blocking the release of histone deacetylase and preventing the binding of p300 to chromatin.
2004 Feb 6
A comparison of the insulin-sensitive transport of chromium in healthy and model diabetic rats.
2004 Mar
Effect of chromium on the insulin resistance in patients with type II diabetes mellitus.
2005
[Effects of chromium supplementation on IRS-1 expression of skeletal muscle in diabetic rats].
2005 Jan
[Regulatory effects of micronutrient complex on the expression of Th1 and Th2 cytokines in diabetic C57BL mice].
2005 Jan
An ecological study of the association of environmental chemicals on breast cancer incidence in Texas.
2005 Jul
Effect of chromium picolinate on modified forced swimming test in diabetic rats: involvement of serotonergic pathways and potassium channels.
2006 Feb
Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1alpha) and HIF-regulated genes.
2006 Jun 15
Functional characteristics of NaS2, a placenta-specific Na+-coupled transporter for sulfate and oxyanions of the micronutrients selenium and chromium.
2006 Jun-Jul
Matrix metalloproteinases and their inhibitors as biomarkers for metal toxicity in vitro.
2006 Oct
Oxidative stress and genotoxic effects in gill and kidney of Anguilla anguilla L. exposed to chromium with or without pre-exposure to beta-naphthoflavone.
2006 Sep 19
Characterization and distribution of the selected metals in the scalp hair of cancer patients in comparison with normal donors.
2007 Sep
Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: a placebo-controlled, double-blind randomized clinical trial.
2007 Spring
Arsenite and cadmium, but not chromium, induce NAD(P)H:quinone oxidoreductase 1 through transcriptional mechanisms, in spite of post-transcriptional modifications.
2008 Aug
Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells.
2008 Feb 1
Cholesterol efflux and the effect of combined treatment with niacin and chromium on aorta of hyperlipidemic rat.
2008 Jan
Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium.
2008 Jan
Blood pressure lowering effects of niacin-bound chromium(III) (NBC) in sucrose-fed rats: renin-angiotensin system.
2008 Jul
Chromium (VI) induces insulin resistance in 3T3-L1 adipocytes through elevated reactive oxygen species generation.
2008 Jun
Deposition of nickel, chromium, and cobalt on the skin in some occupations - assessment by acid wipe sampling.
2008 Jun
Gene expression profiles in rainbow trout, Onchorynchus mykiss, exposed to a simple chemical mixture.
2008 Mar
Chromium (D-phenylalanine)3 supplementation alters glucose disposal, insulin signaling, and glucose transporter-4 membrane translocation in insulin-resistant mice.
2008 Oct
Effect of chromium supplementation on the diabetes induced-oxidative stress in liver and brain of adult rats.
2009 Dec
Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury.
2009 Jan
Chromium(III) induces oxidative stress in goldfish liver and kidney.
2009 Jun 4
Multiple metals predict prolactin and thyrotropin (TSH) levels in men.
2009 Oct
Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice.
2010 Jul 2
Maternal dietary chromium restriction programs muscle development and function in the rat offspring.
2010 Mar
Evaluation of insulin binding and signaling activity of newly synthesized chromium(III) complexes in vitro.
2010 Mar-Apr
Simultaneous analysis of the local and systemic immune responses in mice to study the occupational asthma mechanisms induced by chromium and platinum.
2010 Nov 9
Chromium (VI) inhibits mouse metallothionein-I gene transcription by modifying the transcription potential of the co-activator p300.
2011 Apr
Chromium improves production and alters metabolism of early lactation cows in summer.
2011 Feb
Chromium (D-phenylalanine)3 alleviates high fat-induced insulin resistance and lipid abnormalities.
2011 Jan
Cardioprotective effects of selenium on chromium (VI)-induced toxicity in female rats.
2011 Mar
Comparison of gene expression profiles in chromate transformed BEAS-2B cells.
2011 Mar 18
The effects of chromium complex and level on glucose metabolism and memory acquisition in rats fed high-fat diet.
2011 Nov
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Chromium is also used intravenously (by IV) as a supplement in nutritional IV drips. https://www.webmd.com/vitamins/ai/ingredientmono-932/chromium
The currently accepted value for chromium dietary intake is 25 mcg/day for women and 35 mcg/day for men. Daily dosages used in clinical trials for periods of up to 9 months range as follows: brewer's yeast up to 400 mcg/day; chromium chloride 50 to 600 mcg/day; chromium nicotinate 200 to 800 mcg/day; chromium picolinate 60 to 1,000 mcg/day. The potential for genotoxic effects exists at higher dosages.
Route of Administration: Oral
Name Type Language
CHROMIUM
HSDB   INCI   MI   VANDF   WHO-DD  
INCI  
Official Name English
BIOCHROME
Preferred Name English
CHROMIUM [VANDF]
Common Name English
CHROMIUM, METALLIC [IARC]
Common Name English
CHROMIUM [HSDB]
Common Name English
DINAKROME
Common Name English
CHROMIUM, ELEMENTAL
Common Name English
Chromium [WHO-DD]
Common Name English
CHROMIUM [MI]
Common Name English
Classification Tree Code System Code
Food Contact Sustance Notif, (FCN No.) FCN NO. 581
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 586
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 583
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 578
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
NCI_THESAURUS C637
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 590
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 588
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 579
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 584
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 580
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
NCI_THESAURUS C896
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 582
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 589
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 585
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
NDF-RT N0000185508
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 591
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 587
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID3031022
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY
RXCUI
2496
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY RxNorm
NDF-RT
N0000171131
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY Allergens [Chemical/Ingredient]
NCI_THESAURUS
C370
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY
FDA UNII
0R0008Q3JB
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY
MERCK INDEX
m3505
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY Merck Index
HSDB
910
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY
SMS_ID
100000090349
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY
CHEBI
28073
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY
NDF-RT
N0000184306
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY Cell-mediated Immunity [PE]
DRUG BANK
DB11136
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY
EVMPD
SUB13362MIG
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY
MESH
D002857
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY
DAILYMED
0R0008Q3JB
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY
ECHA (EC/EINECS)
231-157-5
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY
PUBCHEM
23976
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY
NDF-RT
N0000175629
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY Increased Histamine Release [PE]
CAS
7440-47-3
Created by admin on Mon Mar 31 18:23:21 GMT 2025 , Edited by admin on Mon Mar 31 18:23:21 GMT 2025
PRIMARY